缺血性心肌病中右心室功能不全的演变、冠状动脉旁路移植手术及结局
本研究基于缺血性心力衰竭外科治疗试验,纳入1042例有基线右心室超声评估的缺血性心肌病患者,分析右心室功能不全对预后及冠状动脉旁路移植手术与单纯药物治疗选择的影响,中位随访9.8年。结果显示右心室功能不全与更差预后相关,中重度右心室功能不全患者接受冠状动脉旁路移植手术未获得额外生存获益,右心室功能演变具有重要预后意义。
要点
- 中位随访9.8年,轻度右心室功能不全患者死亡风险调整后风险比1.32(95%CI 1.06-1.65),中重度为1.75(95%CI 1.40-2.19)。
- 中重度右心室功能不全患者中,冠状动脉旁路移植手术与单纯药物治疗相比无额外生存获益(aHR 0.98;95%CI 0.67-1.43)。
- 右心室功能演变与死亡风险梯度相关,从持续正常到恢复、新发及持续右心室功能不全风险递增。
核心结论
- 右心室功能不全与缺血性心肌病患者更差预后相关,中重度右心室功能不全患者接受冠状动脉旁路移植手术未获得额外生存获益。
- 右心室功能的演变具有重要预后意义,强调治疗前后右心室评估的重要性。
研究设计与样本
- 研究基于缺血性心力衰竭外科治疗试验,纳入1042例有基线超声心动图右心室评估的缺血性心肌病患者。
主要发现
- 1042例患者中,轻度右心室功能不全143例(13.7%),中重度右心室功能不全142例(13.6%)。
- 中位随访9.8年,与右心室功能正常患者相比,轻度右心室功能不全患者死亡风险调整后风险比1.32(95%CI 1.06-1.65),中重度右心室功能不全患者调整后风险比1.75(95%CI 1.40-2.19)。
- 中重度右心室功能不全患者中,冠状动脉旁路移植手术与单纯药物治疗相比无额外生存获益(aHR 0.98;95%CI 0.67-1.43)。
- 746例有治疗前后右心室评估的患者中,死亡风险梯度从持续右心室功能正常、右心室功能不全恢复、新发右心室功能不全到持续右心室功能不全递增。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Whether the presence or evolution of right ventricular dysfunction (RVD) affects the prognosis and the therapeutic choice between coronary artery bypass grafting (CABG) or medical therapy alone in patients with ischaemic cardiomyopathy (ICM) remains unclear. We investigate the prognostic and therapeutic implications of RVD in patients with ICM. METHODS: Patients with baseline echocardiographic right ventricular (RV) assessment were included from the Surgical Treatment of Ischaemic Heart Failure trial. The primary outcome was all-cause mortality. RESULTS: Of 1212 patients enrolled in the Surgical Treatment of Ischaemic Heart Failure trial, 1042 patients were included, with 143 (13.7%) mild RVD and 142 (13.6%) moderate-to-severe RVD. After a median follow-up of 9.8 years, compared with patients with normal RV function, patients with RVD had a higher risk of mortality [mild RVD: adjusted hazard ratio (aHR) 1.32; 95% confidence interval (CI) 1.06-1.65; moderate-to-severe RVD: aHR, 1.75; 95% CI 1.40-2.19]. Among patients with moderate-to-severe RVD, CABG provided no additional survival benefits compared to medical therapy alone (aHR: 0.98; 95% CI: 0.67-1.43). Among 746 patients with pre- and post-therapeutic RV assessment, a gradient risk for death increased from patients with consistent normal RV function, to patients with recovery from RVD, new-onset RVD and persistent RVD. CONCLUSIONS: RVD was associated with a worse prognosis in patients with ICM, and CABG provided no additional survival benefits to patients with moderate-to-severe RVD. The evolution of RV function had important prognostic implications, which emphasized the importance of both pre- and post-therapeutic RV assessment.
引用
- Zhou Z, Jian B, Fu G, et al. Evolution, coronary artery bypass surgery and outcomes of right ventricular dysfunction in ischaemic cardiomyopathy. Eur J Cardiothorac Surg. 2023. PMID: 37021931. doi:10.1093/ejcts/ezad136
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。